Agneta Nordberg

54.4k total citations · 5 hit papers
503 papers, 25.9k citations indexed

About

Agneta Nordberg is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Agneta Nordberg has authored 503 papers receiving a total of 25.9k indexed citations (citations by other indexed papers that have themselves been cited), including 232 papers in Molecular Biology, 227 papers in Physiology and 153 papers in Cellular and Molecular Neuroscience. Recurrent topics in Agneta Nordberg's work include Alzheimer's disease research and treatments (219 papers), Nicotinic Acetylcholine Receptors Study (166 papers) and Cholinesterase and Neurodegenerative Diseases (134 papers). Agneta Nordberg is often cited by papers focused on Alzheimer's disease research and treatments (219 papers), Nicotinic Acetylcholine Receptors Study (166 papers) and Cholinesterase and Neurodegenerative Diseases (134 papers). Agneta Nordberg collaborates with scholars based in Sweden, United States and United Kingdom. Agneta Nordberg's co-authors include Bengt Winblad, Ove Almkvist, Bengt Långström, Ewa Hellström‐Lindahl, Anders Wall, David Paterson, Konstantinos Chiotis, Anne‐Lie Svensson, Amelia Marutle and Taher Darreh‐Shori and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and NeuroImage.

In The Last Decade

Agneta Nordberg

493 papers receiving 25.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neuronal nicotinic receptors in the human brain

2000 645 citations Agneta Nordberg et al. profile →
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

2021 598 citations Giovanni B. Frisoni, Agneta Nordberg et al. profile →
PET imaging of amyloid deposition in patients with mild cognitive impairment

2007 515 citations Ove Almkvist, Anders Wall et al. Neurobiology of Aging profile →
Tau PET imaging in neurodegenerative tauopathies—still a challenge

2019 425 citations Antoine Leuzy, Konstantinos Chiotis et al. profile →
Biological subtypes of Alzheimer disease

2020 235 citations Daniel Ferreira, Agneta Nordberg et al. Neurology profile →

Peers

Agneta Nordberg

PHYSI

CMN

PHARM

PMH

Ann M. Saunders United States

John H. Growdon United States

Paul Aisen United States

Alison Goate United States

Leon J. Thal United States

Martin R. Farlow United States

Allen D. Roses United States

Vahram Haroutunian United States

Ralph N. Martins Australia

Karen Duff United States

Ann M. Saunders United States

Agneta Nordberg

19.6k ×1.8

PHYSI

11.4k ×1.1

4.2k ×0.6

CMN

3.3k ×0.5

PHARM

7.9k ×1.4

PMH

Citations per year, relative to Agneta Nordberg Agneta Nordberg (= 1×) peers Ann M. Saunders

Countries citing papers authored by Agneta Nordberg

Since Specialization

Citations

This map shows the geographic impact of Agneta Nordberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta Nordberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta Nordberg more than expected).

Fields of papers citing papers by Agneta Nordberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agneta Nordberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta Nordberg. The network helps show where Agneta Nordberg may publish in the future.

Co-authorship network of co-authors of Agneta Nordberg

This figure shows the co-authorship network connecting the top 25 collaborators of Agneta Nordberg. A scholar is included among the top collaborators of Agneta Nordberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agneta Nordberg. Agneta Nordberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kirabali, Tunahan, Uwe Konietzko, Daniel Razansky, et al.. (2025). Reduced synaptic vesicle protein 2A in extracellular vesicles and brains of Alzheimer’s disease: associations with Aβ, tau, synaptic proteins and APOE ε4. Translational Neurodegeneration. 14(1). 48–48.

García‐Ptacek, Sara, Nenad Bogdanović, Tobias Granberg, et al.. (2025). Find-DLB: a naturalistic cohort of patients presenting with clinical features of dementia with Lewy bodies to a specialized cognitive clinic. European Geriatric Medicine. 17(1). 309–321.

Mohanty, Rosaleena, Konstantinos Poulakis, J‐Sebastian Muehlboeck, et al.. (2024). Divergent neurodegenerative patterns: Comparison of [18F] fluorodeoxyglucose-PET- and MRI-based Alzheimer’s disease subtypes. Brain Communications. 6(6). fcae426–fcae426.

Bucci, Marco, et al.. (2023). Levels of plasma neurofilament light and pTau‐181 predict for steeper cognitive decline in Typical AD and Hippocampal‐sparing compared to Limbic‐predominant AD subtype. Alzheimer s & Dementia. 19(S2). 1 indexed citations

Mastenbroek, Sophie E, Arianna Sala, Juan Domingo Gispert, et al.. (2023). Biological and methodological factors underlying a continuous amyloid CSF/PET imbalance model and its association with longitudinal cognition. Alzheimer s & Dementia. 19(S10). 1 indexed citations

Fontana, Igor C., et al.. (2023). Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging Perspective. Cells. 12(11). 1469–1469. 16 indexed citations

Villemagne, Victor L., Frederik Barkhof, Valentina Garibotto, et al.. (2021). Molecular Imaging Approaches in Dementia. Radiology. 298(3). 517–530. 28 indexed citations

Bellaver, Bruna, João Pedro Ferrari‐Souza, Stephen F. Carter, et al.. (2021). Astrocyte Biomarkers in Alzheimer Disease. Neurology. 96(24). e2944–e2955. 80 indexed citations

Kuang, Guanglin, N. Arul Murugan, Yang Zhou, Agneta Nordberg, & Hans Ågren. (2020). Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils. ACS Chemical Neuroscience. 11(6). 900–908. 38 indexed citations

10.

Almkvist, Ove, Elena Rodriguez‐Vieitez, Steinunn Þórðardóttir, et al.. (2019). Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes. Neurobiology of Aging. 82. 40–47. 7 indexed citations

11.

Jonasson, My, Anders Wall, Konstantinos Chiotis, et al.. (2019). Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [18F]THK5317 PET. NeuroImage Clinical. 22. 101681–101681. 2 indexed citations

12.

Garibotto, Valentina, Karl Herholz, Marina Boccardi, et al.. (2017). Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52. 183–195. 59 indexed citations

13.

Kuang, Guanglin, Yang Zhou, Rongfeng Zou, et al.. (2017). Characterization of the binding mode of the PET tracer [¹⁸F]ASEM to a chimera structure of the α7 nicotinic acetylcholine receptor. RSC Advances. 7(32). 19787–19793. 4 indexed citations

14.

Chiotis, Konstantinos, Laure Saint‐Aubert, Marina Boccardi, et al.. (2017). Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52. 214–227. 48 indexed citations

15.

Marutle, Amelia, Per‐Göran Gillberg, Wenfeng Yu, et al.. (2013). 3H-Deprenyl and 3H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain. Journal of Neuroinflammation. 10(1). 90–90. 54 indexed citations

16.

Zhang, Xiao, Chuan Liu, Hui Miao, Ze‐Hui Gong, & Agneta Nordberg. (1998). Postnatal changes of nicotinic acetylcholine receptor α2, α3, α4, α7 and β2 subunits genes expression in rat brain. International Journal of Developmental Neuroscience. 16(6). 507–518. 111 indexed citations

17.

Berglund, Ulrika Warpman & Agneta Nordberg. (1995). Epibatidine and ABT 418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brains. Neuroreport. 6(17). 2419–2423. 123 indexed citations

18.

Nordberg, Agneta & Bengt Winblad. (1993). Cholinesterase inhibitors in Alzheimer's disease. Munksgaard eBooks. 1 indexed citations

19.

Cacabelos, Ramón, A. Hofman, Michael Mullan, et al.. (1993). Alzheimer's disease: Scientific progress for future trends. Drug News & Perspectives. 6. 242–244. 2 indexed citations

20.

Zhang, Xiao, Göran Wahlström, & Agneta Nordberg. (1990). Influence of development and aging on nicotinic receptor subtypes in rodent brain. International Journal of Developmental Neuroscience. 8(6). 715–721. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact